Mark T. Iwicki - Insider Trading & Ownership

Entity: Individual
Location: 84 Waterford Drive, Marlborough, MA
Summary: The estimated net worth of Mark T. Iwicki is at least $2.8M dollars as of February 26, 2025. Mark T. Iwicki is the CHIEF EXECUTIVE OFFICER, Director of KALA BIO, Inc. and owns shares of KALA BIO, Inc. (KALA) stock worth about $2.14M. Mark T. Iwicki is the Director of Q32 Bio Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $343K. Mark T. Iwicki is the Director of Aerovate Therapeutics, Inc. and owns shares of Aerovate Therapeutics, Inc. (AVTE) stock worth about $205K. Mark T. Iwicki is the Director of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $120K.
All Insider Reports: All Insider Reports

Ownership of Mark T. Iwicki

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
KALA	KALA BIO, Inc.	CHIEF EXECUTIVE OFFICER, Director	$2.14M	-$161K	-7.01%	Jan 6, 2025
QTTB	Q32 Bio Inc.	Director	$343K			Feb 24, 2025
AVTE	Aerovate Therapeutics, Inc.	Director	$205K			Jun 5, 2024
MRUS	Merus N.V.	Director	$120K			May 7, 2024
AKRO	Akero Therapeutics, Inc.	Director				Jun 8, 2024
IKT	Inhibikase Therapeutics, Inc.	Chief Executive Officer, Director				Feb 21, 2025
THRD	Third Harmonic Bio, Inc.	Director				Jun 6, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.